Min Yu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Hepatitis C Virus

Immune Response

Top Venues

American journal of hematology

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mei Jiang, Xuemei Wang, Min Yu, Shuling Jiang, Miao Hong, Yuru Zhou, Fei Li, Hongxing Liu, Zhanglin Zhang
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American journal of hematology (2024)
Mei Jiang, Xuemei Wang, Min Yu, Shuling Jiang, Miao Hong, Yuru Zhou, Fei Li, Hongxing Liu, Zhanglin Zhang
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American journal of hematology 99 (5) (2024)
Mei Jiang, Xuemei Wang, Min Yu, Shuling Jiang, Miao Hong, Yuru Zhou, Fei Li, Hongxing Liu, Zhanglin Zhang
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American journal of hematology 99 (5) (2024)
Mei Jiang, Xuemei Wang, Min Yu, Shuling Jiang, Miao Hong, Yuru Zhou, Fei Li, Hongxing Liu, Zhanglin Zhang
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American journal of hematology 99 (5) (2024)
Mei Jiang, Xuemei Wang, Min Yu, Shuling Jiang, Miao Hong, Yuru Zhou, Fei Li, Hongxing Liu, Zhanglin Zhang
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American journal of hematology 99 (5) (2024)
Min Yu, Qian Zhang, Fancong Kong, Ling Qi, Yafang Pu, Lugui Qiu, Jian-Xiang Wang, Fei Li
Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review and Meta-Analysis. Human gene therapy 34 (5-6) (2023)